新型药物疗法和牛皮治疗的突破:2024年及以后
Antonio Portarapillo1, Luca Potestio1, Nello Tommasino1
1Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Expert opinion on pharmacotherapy
|June 25, 2024
概括
目前的牛皮治疗方法面临着不良遵守性和副作用等挑战. 新的局部和全身疗法正在开发中,为中度至重度的牛皮提供更安全,更个性化的选择.
科学领域:
- 皮肤病学和免疫学,专注于牛皮的管理.
背景情况:
- 目前的牛皮治疗方法有局限性,包括患者的遵从性,并发症的安全性问题以及可变的疗效.
- 对于中度至重度牛皮患者来说,仍然存在未满足的需求,需要扩大治疗选择.
研究的目的:
- 审查关于牛皮治疗的现有文献.
- 提供有关牛皮管理当前和未来趋势的概述.
主要方法:
- 使用PubMed和clinicaltrials.gov.gov进行了全面的文献搜索.
- 审查的重点是英语医学文献.
主要成果:
- 几项临床试验正在研究新的局部和全身牛皮治疗方法.
- 新的治疗药物预计将获得批准,扩大治疗选择.
结论:
- 尽管有治疗方法,但对于中度至重度的牛皮需要个性化治疗方法.
- 开发中的创新疗法有望为抗性牛皮的有效和安全管理提供希望.
相关概念视频
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drug Administration and Therapy Phases: Overview
447
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
447


